Rukobia Approved for Patients With Multidrug-Resistant HIV
TUESDAY, July 7, 2020 — A new type of antiretroviral medication, Rukobia (fostemsavir), has been approved for people with HIV who have not had success with other therapies, the U.S. Food and Drug Administration announced Thursday. Rukobia, 600 mg extended-release tablets that are taken twice daily, is part of a new class of antiretroviral treatments… Read More »